Felipe Duran
Director of Finance/CFO bei IBIO, INC.
Vermögen: 5 026 $ am 31.03.2024
Profil
Felipe Duran is currently the Chief Financial Officer at iBio, Inc. He previously worked as the Chief Financial Officer-Lupin Latin America at Lupin Pharmaceuticals, Inc. from 2016 to 2021 and as the Manager-Financial Planning & Analysis at Noven Pharmaceuticals, Inc. Mr. Duran obtained his undergraduate degree and MBA from the University of Miami.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IBIO, INC.
0,01% | 25.10.2023 | 1 238 ( 0,01% ) | 5 026 $ | 31.03.2024 |
Aktive Positionen von Felipe Duran
Unternehmen | Position | Beginn |
---|---|---|
IBIO, INC. | Director of Finance/CFO | 13.02.2023 |
Ehemalige bekannte Positionen von Felipe Duran
Unternehmen | Position | Ende |
---|---|---|
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Director of Finance/CFO | 01.01.2021 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | - |
Ausbildung von Felipe Duran
University of Miami | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IBIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Health Technology |